T. Rowe Price Enters 2021 With Record AUM
We're increasing our fair value estimate for the wide-moat asset manager.
We've increased our fair value estimate for T. Rowe Price (TROW) to $170 per share from $125 to account for the continued recovery in the equity, credit, and currency markets following the steep COVID-19-induced sell-off in the March quarter of 2020. Roughly half the change comes from our belief that T. Rowe Price will have more in assets under management during 2021-25 than we previously forecast (especially after adjusting for the timing and severity of near-term market corrections), with the remainder coming from a slightly better fee and margin outlook as well as a slightly lower statutory tax rate (we had expected to see a greater push to increase the U.S. corporate tax rate in the near term). Our fair value estimate implies a P/E multiple of 15.0 times our 2021 earnings estimate and 14.8 times our 2022 earnings estimate, which on a multiple basis is in line with our previous fair value estimate.
T. Rowe Price closed out 2020 with a record $1.470 trillion in managed assets, up 12.2% sequentially and 21.9% year over year. Net inflows of $2.2 billion during the fourth quarter were better than our expectations and on par with the $2.3 billion quarterly run rate we've seen from the firm since the end of the 2008-09 financial crisis. While average AUM was up 20.0% year over year during the December quarter, T. Rowe Price reported an 18.0% increase in fourth-quarter revenue compared with the prior-year period due to product mix shift and a slight decline in the firm's effective fee rate. Full-year top-line growth of 10.5% was better than our forecast of mid- to high-single-digit growth. Adjusted GAAP operating margins of 44.2% during 2020 were 170 basis points higher than the year-ago period, as expenses rose at a slower rate than revenue. Our new five-year forecast calls for margins of 44%-46% even as the firm invests in key regions and channels to help drive growth.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Greggory Warren does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.